8.2. summary evidence recommendations follow-up patients transurethral resection bladder non-muscle-invasive bladder cancer. summary evidencelethe first cystoscopy transurethral resection bladder 3 months important prognostic indicator recurrence progression.1athe risk upper urinary tract recurrence increases patients multiple- high-risk tumours.3 recommendationsstrength ratingbase follow-up tat1 tumours carcinoma situ (cis) regular cystoscopy.strongpatients low-risk ta tumours undergo cystoscopy three months. negative, subsequent cystoscopy advised nine months later, yearly five years.weakpatients high-risk high-risk tumours treated conservatively undergo cystoscopy urinary cytology three months. negative, subsequent cystoscopy cytology repeated every three months period two years, every six months thereafter five years, annually lifelong.weakperform cystoscopy three months patients intermediate-risk ta low-grade tumours. negative, subsequent cystoscopy repeated every six months two years, annually ten years. subgroup intermediate-risk high grade followed high-risk.weaktake regular long-term upper tract imaging (computed tomography urography) high-risk high-risk tumours.weakperform endoscopy anaesthesia bladder biopsies office cystoscopy shows suspicious findings urinary cytology positive.strongduring follow-up patients positive cytology visible tumour bladder, mapping biopsies pdd-guided biopsies (if equipment available) investigation extravesical locations (ct urography, prostatic urethra biopsy) recommended.strong